Teriflunomide Tablet, Film Coated
Product Images NDC 0480-3157
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Teriflunomide (NDC 0480-3157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
1 (Image 2)
This appears to be a table showing the results of a study comparing the effectiveness of Teriflunomide versus a placebo. The table lists the number of participants at risk and the weeks of the study. There are also percentages indicating the effectiveness of Teriflunomide versus the placebo. However, without more context, it is unclear what the study was for or what the percentages represent.*
1 (Image 3)
This is a data table showing the percentage of sustained disability progression for 12 weeks for Placebo, 7mg Teriflunomide, and 14mg Teriflunomide. The results indicate that compared to the placebo, there is a significant difference in disability progression for those treated with 14mg of Teriflunomide. The table also lists the number of people at risk for each treatment group during the specified time periods.*
1 (Image 4)
1 (Image 5)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.